I-123-FP-CIT

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameI-123-FP-CIT
Drug Alias Nameradiolabeled dopamine antagonist (Siemens Medical Solutions/University of Minnesota)I-123-FP-CIT
ClassificationOther
Mechanisms of ActionSPECT contrast agent
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSiemens Medical Solutions Molecular Imaging
China Registration ClassN/A

Develop Information

Active CompaniesSiemens Medical Solutions Molecular ImagingUniversity Of Minnesota
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A